Suppr超能文献

智力发育迟缓儿童及青少年中的广泛性发育障碍、行为问题和精神药物使用情况

Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.

作者信息

de Bildt Annelies, Mulder Erik J, Scheers Tom, Minderaa Ruud B, Tobi Hilde

机构信息

University Medical Center Groningen/Accare, University Center for Child and Adolescent Psychiatry, PO Box 660, 9700 AR Groningen, The Netherlands.

出版信息

Pediatrics. 2006 Dec;118(6):e1860-6. doi: 10.1542/peds.2005-3101.

Abstract

OBJECTIVE

This study investigated the interrelationship between psychopharmacotherapy in general and the use of specific psychotropic drugs and pervasive developmental disorder and other behavior problems in children and adolescents with mental retardation.

METHODS

A total of 862 participants 4 to 18 years of age, including all levels of mental retardation, were recruited through facilities for children with mental retardation in Friesland, The Netherlands. Information on medication was collected through parent interviews. Behavior problems were investigated with a standardized parent questionnaire (Developmental Behavior Checklist). A pervasive developmental disorder classification was based on the Pervasive Developmental Disorder in Mental Retardation Scale, completed by psychologists or teachers. Logistic regression analysis was used to investigate the relationship between the use of psychotropic drugs and pervasive developmental disorder and other behavioral problems, in the presence of possible confounders.

RESULTS

One of 10 participants used psychotropic medication. The main factors associated with psychotropic drug use were pervasive developmental disorder and disruptive behavior. The level of functioning was also associated. Self-absorbed behavior was statistically significantly associated with clonidine use and disruptive behavior with stimulant use. Pervasive developmental disorder and communication problems were the main factors associated with the use of antipsychotic drugs. Age also played a role, whereas gender, living situation, and level of mental retardation did not.

CONCLUSIONS

Antipsychotic drugs were associated with pervasive developmental disorder, whereas clonidine and stimulants were associated with self-absorbed and disruptive behavior, respectively. Although clonidine and risperidone are not registered for the problems reported and the other nonstimulants were only sometimes used on-label, their use was associated with specific psychiatric or behavioral problems.

摘要

目的

本研究调查了一般心理药物治疗以及特定精神药物的使用与智力障碍儿童及青少年广泛性发育障碍和其他行为问题之间的相互关系。

方法

通过荷兰弗里斯兰省的智力障碍儿童机构招募了862名4至18岁的参与者,涵盖了所有智力障碍水平。通过家长访谈收集用药信息。使用标准化的家长问卷(发育行为检查表)调查行为问题。广泛性发育障碍分类基于智力障碍中的广泛性发育障碍量表,由心理学家或教师完成。在存在可能的混杂因素的情况下,使用逻辑回归分析来研究精神药物的使用与广泛性发育障碍和其他行为问题之间的关系。

结果

每10名参与者中有1人使用精神药物。与使用精神药物相关的主要因素是广泛性发育障碍和破坏性行为。功能水平也与之相关。自我专注行为在统计学上与使用可乐定显著相关,破坏性行为与使用兴奋剂显著相关。广泛性发育障碍和沟通问题是与使用抗精神病药物相关的主要因素。年龄也起到了作用,而性别、生活状况和智力障碍水平则没有。

结论

抗精神病药物与广泛性发育障碍相关,而可乐定和兴奋剂分别与自我专注行为和破坏性行为相关。尽管可乐定和利培酮未被注册用于所报告的问题,且其他非兴奋剂仅有时按标签使用,但其使用与特定的精神或行为问题相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验